Survival in small cell lung cancer is independent of tumor expression of VEGF and COX-2.

The Biology of Vascular Endothelial Growth Factor

1997 • 4,359 citations

Role of angiogenesis in tumor growth and metastasis

2002 • 2,412 citations

Cyclooxygenase Regulates Angiogenesis Induced by Colon Cancer Cells

1998 • 2,282 citations

The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing

1991 • 1,991 citations

Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors.

2000 • 1,310 citations

Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer.

1995 • 1,271 citations

Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas.

1998 • 825 citations

Expression of cyclooxygenase-2 in human lung carcinoma.

1998 • 729 citations

Prognostic value of vascular endothelial growth factor expression in gastric carcinoma

1996 • 648 citations

Assignment of the Vascular Endothelial Growth Factor Gene to Human Chromosome 6p21.3

1996 • 473 citations

Tumor angiogenesis in breast cancer: Its importance as a prognostic indicator and the association with vascular endothelial growth factor expression

1995 • 376 citations

Cyclooxygenase-2 inhibitor induces apoptosis and enhances cytotoxicity of various anticancer agents in non-small cell lung cancer cell lines.

2000 • 322 citations

Prognostic significance of elevated cyclooxygenase 2 expression in primary, resected lung adenocarcinomas.

1999 • 315 citations

Different angiogenic pathways characterize superficial and invasive bladder cancer.

1995 • 293 citations

High pre-treatment serum level of vascular endothelial growth factor (VEGF) is associated with poor outcome in small-cell lung cancer

1998 • 275 citations

Vascular Endothelial Growth Factor 189 mRNA Isoform Expression Specifically Correlates With Tumor Angiogenesis, Patient Survival, and Postoperative Relapse in Non–Small-Cell Lung Cancer

2001 • 213 citations

Prevention of NNK-induced lung tumorigenesis in A/J mice by acetylsalicylic acid and NS-398.

1998 • 204 citations

Synergistic effects of new chemopreventive agents and conventional cytotoxic agents against human lung cancer cell lines.

1999 • 187 citations

Vascular endothelial growth factor expression in non-small-cell lung cancer: Prognostic significance in squamous cell carcinoma

1998 • 175 citations

Correlation of total VEGF mRNA and protein expression with histologic type, tumor angiogenesis, patient survival and timing of relapse in non-small-cell lung cancer

2000 • 145 citations

Small cell lung carcinoma (SCLC): the angiogenic phenomenon

2002 • 136 citations

Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer.

1998 • 132 citations

Increased vascular endothelial growth factor and vascular endothelial growth factor–c and decreased nm23 expression associated with microdissemination in the lymph nodes in stage i non–small cell lung cancer

2000 • 107 citations

Non-small cell lung cancer cycloxygenase activity and proliferation are inhibited by non-steroidal antiinflammatory drugs.

1998 • 106 citations

Vascular endothelial growth factor and lymph node metastasis in primary lung cancer

1997 • 79 citations

Cyclooxygenase‐2 (COX‐2) mRNA Expression Levels in Normal Lung Tissues and Non‐small Cell Lung Cancers

1999 • 77 citations

Expression and localization of cyclo-oxygenase isoforms in non-small cell lung cancer

1999 • 54 citations

Relationship between vessel density and expression of vascular endothelial growth factor and basic fibroblast growth factor in small cell lung cancer in vivo and in vitro.

2000 • 47 citations

Prostaglandin and thromboxane synthesis by Lewis lung carcinoma during growth.

1985 • 38 citations

Association of a functional prostaglandin E2-protein kinase A coupling with responsiveness of metastatic Lewis lung carcinoma variants to prostaglandin E2 and to prostaglandin E2-producing nonmetastatic Lewis lung carcinoma variants.

1990 • 33 citations

Immunohistochemical study on tumor angiogenic factors in non-small cell lung cancer.

2000 • 26 citations